€4.85
3.53%
Madrid, Oct 20, 05:35 pm CEST. Closed.
ISIN
ES0134950F36
Symbol
FAE

Faes Farma SAReg Target price 2026 - Analyst rating & recommendation

Faes Farma SAReg Classifications & Recommendation

Buy
70%
Hold
30%

Faes Farma SAReg Price Target

Target Price €5.51
Price €4.85
Potential
Number of Estimates 7
7 Analysts have issued a price target Faes Farma SAReg 2027 . The average Faes Farma SAReg target price is €5.51. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend Faes Farma SAReg to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Faes Farma SAReg stock has an average upside potential 2027 of . Most analysts recommend the Faes Farma SAReg stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million € ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

7 Analysts have issued a sales forecast Faes Farma SAReg 2026 . The average Faes Farma SAReg sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 €610m 23.66%
2026
2027
2028

7 Analysts have issued an Faes Farma SAReg EBITDA forecast 2026. The average Faes Farma SAReg EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €118m 8.75%
2026
2027
2028

EBITDA Margin

2025 19.26% 26.21%
2026
2027
2028

7 Faes Farma SAReg Analysts have issued a net profit forecast 2026. The average Faes Farma SAReg net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €79.6m 28.49%
2026
2027
2028

Net Margin

2025 13.04% 42.18%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share € ??? ???
??? ???
P/E ???
EV/Sales ???

7 Analysts have issued a Faes Farma SAReg forecast for earnings per share. The average Faes Farma SAReg EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €0.25 30.56%
2026
2027
2028

P/E ratio

Current 17.33 32.29%
2026
2027
2028

Based on analysts' sales estimates for 2026, the Faes Farma SAReg stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.47 9.19%
2026
2027
2028

P/S ratio

Current 2.10 20.86%
2026
2027
2028

Current Faes Farma SAReg Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today